FDA-cleared profile

Merge PACS

Merge Healthcare Incorporated · Radiological images; modality varies or is not specified in FDA list · FDA-cleared (510(k))

Authorized purpose: Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.

Clinical role
Primary image viewing, processing, measurement, reporting, storage access, and workflow orchestration.
Images and patients
Radiological images; modality varies or is not specified in FDA list · Multi-region
Key limitation
Keep in mind: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.
  • Which images or clinical context are in scope?Modality: Radiological images; modality varies or is not specified in FDA list Anatomy or clinical context: Multi-region Input: Supported DICOM and non-DICOM clinical images and related patient or workflow data.
  • Who uses it?Intended users: Radiologists, cardiologists, technologists, sonographers, surgeons, and other trained clinical users.
  • What does the software produce?Output: Displayed images, measurements, segmentations, reformats, reports, and routed clinical objects.
  • What is its most important limitation?Key limitation: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.

Clinical takeaway. Clinical role: Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.

Evidence takeaway. Evidence from the reviewed source record: The K192455 FDA decision summary describes Merge PACS support for CT, MR, PET, ultrasound, mammography, breast tomosynthesis, CR, DR/DX, nuclear medicine, XA, RF, and secondary-capture image workflows, with professional diagnostic review and reporting. Because the cleared scope spans many modalities, the directory preserves a variable or unspecified modality rather than forcing one modality label; no AI classifier sensitivity or specificity is established.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Merge PACS is a multi-modality image-management and diagnostic-viewing system for processing, displaying, communicating, reporting, printing, storing, and retrieving supported DICOM and related clinical images for radiologists, surgeons, referring physicians, and other authorized users.
  • Exact FDA submission
  • Checked 2026-09-03
Workflow role
Primary image viewing, processing, measurement, reporting, storage access, and workflow orchestration.
  • Exact FDA submission
  • Checked 2026-09-03
Required input
Supported DICOM and non-DICOM clinical images and related patient or workflow data.
  • Exact FDA submission
  • Checked 2026-09-03
Output and clinician action
Displayed images, measurements, segmentations, reformats, reports, and routed clinical objects.
  • Exact FDA submission
  • Checked 2026-09-03
Care setting
Enterprise hospital and outpatient diagnostic-imaging environments.
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
Radiologists, cardiologists, technologists, sonographers, surgeons, and other trained clinical users.
  • Exact FDA submission
  • Checked 2026-09-03
Limitations
Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
  • Exact FDA submission
  • Checked 2026-09-03
Evidence summary
The K192455 FDA decision summary describes Merge PACS support for CT, MR, PET, ultrasound, mammography, breast tomosynthesis, CR, DR/DX, nuclear medicine, XA, RF, and secondary-capture image workflows, with professional diagnostic review and reporting. Because the cleared scope spans many modalities, the directory preserves a variable or unspecified modality rather than forcing one modality label; no AI classifier sensitivity or specificity is established.
  • Exact FDA submission
  • Checked 2026-09-03

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
The K192455 FDA decision summary describes Merge PACS support for CT, MR, PET, ultrasound, mammography, breast tomosynthesis, CR, DR/DX, nuclear medicine, XA, RF, and secondary-capture image workflows, with professional diagnostic review and reporting. Because the cleared scope spans many modalities, the directory preserves a variable or unspecified modality rather than forcing one modality label; no AI classifier sensitivity or specificity is established.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary endpoint for this system, reconstruction, segmentation, guidance, or quantitative function. Use the task-specific evidence below.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K192455 FDA performance package for Merge PACS

  • DesignManufacturer software, DICOM, image-display, reporting, storage, communication, and usability verification and validation submitted in K192455
  • PopulationMulti-modality DICOM image-management, diagnostic-reading, reporting, communication, storage, and retrieval workflows across the supported clinical departments
  • Scopeexact submission
  • Tested versionMerge PACS (K192455)
  • IndependenceSponsor or vendor study

K192455

Manufacturer evidence submitted for FDA clearance or approval; local clinical, technical, and workflow acceptance remains necessary.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
4 exact-submission FDA recall records in the 2026-09-02 openFDA snapshot identify K192455. Affected model, version, unit, correction, and current manufacturer instructions still require local confirmation. FDA recall Z-3004-2026 is Open, Classified for Merge PACS and Merge OrthoPACS, medical imaging diagnostic workstation. FDA reason: Software issue may cause measurements to be displayed inaccurately. FDA action: Merge Healthcare issued an Urgent Field Safety Notice to its consignees on 7/22/2026 via email with a follow-up telephone call. The notice explained the issue and how to identify it, risk to patient, and requested the following: "Immediate actions to reduce risk to patients Merge Healthcare recommends that customers contact Merge Healthcare Support to identify any affected ultrasound studies and the necessary next steps to be taken. Until the software update is installed, ultrasound measurements performed using the Merge PACS & OrthoPACS Viewer should be confirmed against the measurements acquired at the ultrasound modality." The required actions are as follows: "Merge Healthcare Support will contact all customers to: i) Confirm that you have read and understood this Urgent Field Safety Notice. ii) Assist you in identifying and reviewing any ultrasound studies with measurements that may have been affected. iii) Schedule the installation of the software update that eliminates the root cause of this issue. Please forward this notice to any individuals within the organization that may need to be aware of this notification. Customers should alert any other affiliated parties that may be affected by this Urgent Field Safety Notice. For more information, please contact Merge Healthcare Support at 1-877-741-5369 (available 24 hours a day, 7 days a week) or visit our website: https://www.merative.com/support/merge. FDA recall Z-2874-2026 is Open, Classified for Merge PACS, medical imaging diagnostic workstation. FDA reason: Merge Healthcare has identified a potential issue that may cause thumbnails from a previously opened patient study to be displayed in the Thumbnail Bar while a different patient study is open. FDA action: Merge Healthcare issued an Urgent Field Safety Notice (Revision 2) to its consignees on 6/30/2026 via email. The notice explained the issue and when it may occur, risk to patient, and requested an immediate workaround, a configuration change, be performed to disable automatic refresh of the Thumbnail Bar until a software update is available. The notice also directions the consignee to forward the notice to any individuals within their organization that may need to be aware of this notification. Customers should alert any other affiliated parties that may be affected by this Urgent Field Safety Notice. The notice was followed by telephone calls beginning on 7/6/2026 to ensure the notice was received. For more information, please contact Merge Healthcare Support at 1-877-741-5369 (available 24 hours a day, 7 days a week) or visit our website: https://www.merative.com/support/merge. FDA recall Z-2875-2026 is Open, Classified for Merge OrthoPACS, medical imaging diagnostic workstation. FDA reason: Merge Healthcare has identified a potential issue that may cause thumbnails from a previously opened patient study to be displayed in the Thumbnail Bar while a different patient study is open. FDA action: Merge Healthcare issued an Urgent Field Safety Notice (Revision 2) to its consignees on 6/30/2026 via email. The notice explained the issue and when it may occur, risk to patient, and requested an immediate workaround, a configuration change, be performed to disable automatic refresh of the Thumbnail Bar until a software update is available. The notice also directions the consignee to forward the notice to any individuals within their organization that may need to be aware of this notification. Customers should alert any other affiliated parties that may be affected by this Urgent Field Safety Notice. The notice was followed by telephone calls beginning on 7/6/2026 to ensure the notice was received. For more information, please contact Merge Healthcare Support at 1-877-741-5369 (available 24 hours a day, 7 days a week) or visit our website: https://www.merative.com/support/merge. FDA recall Z-2944-2020 is Terminated for Merge PACS. FDA reason: Measurements done on the Merge PACS generated MPR s may have incorrect measurements. FDA action: The firm, IBM Watson Health, sent an "Urgent Field Safety Notice" dated 05 August 2020 to its customers. The letter described the product, problem, and actions to be taken. The customers were instructed to do the following: Avoid incorrect pixel measurements by using the following workflow: Step 1: Modality acquires a series and generates reformat and sends to Merge PACS Step 2: Radiologist performs measurement on these series from the modality. Avoid black dots that may lead to additional imaging by taking any of the following actions: - Verifying study images either at modality or in another viewer. - Increasing the window level will window out the lowest pixel value (the black dots). - Viewing additional images/series within the study. Viewing of prior series/studies. - Verifying patients history, diagnosis or other clinical data. IBM Watson Health/Merge Healthcare will provide a software correction to address these issues. A representative will be in contact with you to schedule the software update. Please ensure all potential users of Merge PACS v8.1, 8.1.1 and 8.1.2 have received this notice. Please provide this notice to other organizations impacted by this action. If you have any questions regarding this notice, please contact Customer Support at WHISupport@us.ibm.com or 877-741-5369.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04

Each published event was manually matched to the exact FDA submission and affected product or version; a recall does not establish an AI-algorithm defect or current site exposure unless the event states that scope.

recall: Z-3004-2026

Open, Classified

2026-08-21

Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.

recall: Z-2874-2026

Open, Classified

2026-08-04

Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.

recall: Z-2875-2026

Open, Classified

2026-08-04

Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.

recall: Z-2944-2020

Terminated

2020-08-06

Exact native submission match in the checked openFDA snapshot. Published as a product, system, labeling, or postmarket issue; the FDA record does not identify an AI-algorithm defect unless it says so. Confirm affected model, version, units, corrective action, and completion status locally.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging, procedural, or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance or approval.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Supported DICOM and non-DICOM clinical images and related patient or workflow data.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-03 · FDA 510(k) decision summary K192455: Merge PACS

  2. Routing

    Source context, not route validation: Validate modality and archive connectivity, DICOM objects, patient reconciliation, worklists, priors, reporting, identity, routing, display calibration, AI-result ingestion, and downtime recovery.

    Scope: Product family. Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-03 · FDA 510(k) decision summary K192455: Merge PACS · Merge PACS

  3. AI processing

    Source context, not route validation: Web and server software deployed on supported on-premises or contracted hosted infrastructure for the exact release.

    Scope: Product family. Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-03 · FDA 510(k) decision summary K192455: Merge PACS · Merge PACS

  4. Returned objects

    Source context, not route validation: Displayed images, measurements, segmentations, reformats, reports, and routed clinical objects.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-03 · FDA 510(k) decision summary K192455: Merge PACS

  5. Viewer/worklist/report

    Unresolved route: Displayed images, measurements, segmentations, reformats, reports, and routed clinical objects.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-03 · FDA 510(k) decision summary K192455: Merge PACS

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Web and server software deployed on supported on-premises or contracted hosted infrastructure for the exact release.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Integration
Validate modality and archive connectivity, DICOM objects, patient reconciliation, worklists, priors, reporting, identity, routing, display calibration, AI-result ingestion, and downtime recovery.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Training
Only radiologists, cardiologists, technologists, sonographers, surgeons, and other trained clinical users should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring
Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.
  • Product family
  • Checked 2026-09-03

Current vendor materials are product-family evidence for K192455; confirm the exact cleared version, enabled options, deployment, and local compatibility.

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, outputs, and enabled AI functions to K192455 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

Validate modality and archive connectivity, DICOM objects, patient reconciliation, worklists, priors, reporting, identity, routing, display calibration, AI-result ingestion, and downtime recovery.

product family · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally. Vendor statements are current product-family context; confirm the exact cleared release and installed options.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

No exact-product price was found in the reviewed public material; vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: Not every viewer, advanced-visualization, AI, cloud, or integration feature in current family materials belongs to the cleared version; verify licensed components and diagnostic-display requirements.

product family · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes. Vendor statements are current product-family context; confirm the exact cleared release and installed options.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K192455
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Radiological images; modality varies or is not specified in FDA list
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-03
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2019-10-17
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
26Fields reviewed
13Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains no PubMed or ClinicalTrials.gov candidates; no external evidence was promoted. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. 4 FDA recall candidates were manually reviewed: 4 published and 0 rejected as a neighboring or otherwise inapplicable version. Native FDA recall identifiers produced 4 postmarket candidate records; 4 have been reviewed (4 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, fda decision material, vendor product page, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-03 - Exact FDA submission

    Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

11 sources - 3 history items

Source ledger

  1. FDA 510(k) decision summary K192455: Merge PACS

    U.S. Food and Drug Administration - Published 2026-09-03 - Accessed 2026-09-03

    Scope: purpose, modality, anatomy, intendedUsers, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. FDA recall Z-3004-2026: Merge PACS and Merge OrthoPACS, medical imaging diagnostic workstation

    U.S. Food and Drug Administration - Published 2026-08-21 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  4. FDA recall Z-2874-2026: Merge PACS, medical imaging diagnostic workstation

    U.S. Food and Drug Administration - Published 2026-08-04 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  5. FDA recall Z-2875-2026: Merge OrthoPACS, medical imaging diagnostic workstation

    U.S. Food and Drug Administration - Published 2026-08-04 - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  6. FDA recall Z-2944-2020: Merge PACS

    U.S. Food and Drug Administration - Accessed 2026-09-04

    Scope: postmarketSafety, affectedProduct, recallStatus, correctiveAction

  7. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  8. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  9. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  10. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  11. Merge PACS

    Merative - Accessed 2026-09-03

    Scope: productFamilyContext, workflowRole, implementationCapabilities

Research history

  1. K192455 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K190764

SurgicalAR

MEDIVIS, Inc.

Authorized purpose: SurgicalAR displays CT and MR medical images and associated data as two-dimensional, multiplanar, three-dimensional, or volume-rendered views on a workstation, touchscreen, or head-mounted display to support surgical planning and intraoperative review; headset and mobile views are informational and non-diagnostic.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2019-05-13
FDA-cleared K254207

AiORTA - Plan v2.0

ViTAA Medical Solutions, Inc.

Authorized purpose: AiORTA - Plan v2.0 is image-processing and analysis software for the labeled radiotherapy-planning workflow; exact modalities, structures, inputs, outputs, and user-review requirements remain submission-specific.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Multi-region
Decision
2026-03-30

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history